Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are ...

Mizuho upgraded Corvus Pharmaceuticals (CRVS) to Outperform from Neutral with a price target of $12, up from $3.50. The firm significantly ...

Humana’s stock looked to rally Monday. And Mizuho analyst Ann Hynes said she believes a buyout by Cigna Group is likely — ...

Mizuho Financial Group Inc. is preparing for short-term market disruptions if investors’ predictions of a soft landing in the ...

Mizuho initiated coverage of Synopsys (SNPS) with an Outperform rating and $650 price target Electronic design automation is a “stable ...

We recently compiled a list of the 20 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Mizuho upgraded shares of Duke Energy (NYSE:DUK – Free Report) from a neutral rating to an outperform rating in a research ...

Mizuho Financial's asset management business has significant growth potential in the long run. See why MFG stock is a Hold.

Earnings season is about to kick into full swing and Texas Instruments (TXN) is leading off for the semiconductor industry.

Mizuho downgraded shares of American Water Works (NYSE:AWK – Free Report) from an outperform rating to a neutral rating in a ...

Shares of Cigna Group shed 4.3% in recent trading, enough to lead the S&P 500's decliners, in the wake of a Bloomberg report that merger talks with Humana had resumed. The ...

The Bank of New York Mellon Corporation (“BNY”) (NYSE: BK), a global financial services company, and Mizuho Bank, Ltd. (“Mizuho Bank”), the banking arm of Mizuho Financial Group, Inc. (NYSE: MFG) and ...